AGP Picks
View all

Nebraska Tech Daily
Provided by AGP

Nebraska Tech Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Nebraska Tech Daily.

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

Press releases published on May 7, 2026

Cloudera 推出適用於 ServiceNow 的工作流程數據結構零複製連接器
May 7, 2026

Cloudera 推出適用於 ServiceNow 的工作流程數據結構零複製連接器

Indeterminate GlobeNewswire
AIM ImmunoTech Announces 50% Objective Response Rate (ORR) in UPMC Recurrent Ovarian Cancer Phase 2 Clinical Trial, Suggesting Breakthrough Combination Potential
May 7, 2026

AIM ImmunoTech Announces 50% Objective Response Rate (ORR) in UPMC Recurrent Ovarian Cancer Phase 2 Clinical Trial, Suggesting Breakthrough Combination Potential

Indeterminate GlobeNewswire
Inuvo to Host First Quarter 2026 Financial Results Conference Call on Thursday, May 14th at 4:15 P.M. ET
May 7, 2026

Inuvo to Host First Quarter 2026 Financial Results Conference Call on Thursday, May 14th at 4:15 P.M. ET

Indeterminate GlobeNewswire
Theriva™ Biologics presenta los aspectos operativos más destacados y los resultados financieros del primer trimestre de 2026
May 7, 2026

Theriva™ Biologics presenta los aspectos operativos más destacados y los resultados financieros del primer trimestre de 2026

Indeterminate GlobeNewswire
sensiBel’s Optical MEMS Microphone Boosts Audio Quality of mh acoustics’ Newest Ambisonics Microphone
May 7, 2026

sensiBel’s Optical MEMS Microphone Boosts Audio Quality of mh acoustics’ Newest Ambisonics Microphone

Indeterminate GlobeNewswire
Silo Pharma Files Provisional Patent for Ibogaine-Based Therapeutic Targeting Traumatic Brain Injury
May 7, 2026

Silo Pharma Files Provisional Patent for Ibogaine-Based Therapeutic Targeting Traumatic Brain Injury

Indeterminate GlobeNewswire
Ardelyx Presents Analysis Supporting Long-Term Safety of XPHOZAH at NKF’s Spring Clinical Meetings
May 7, 2026

Ardelyx Presents Analysis Supporting Long-Term Safety of XPHOZAH at NKF’s Spring Clinical Meetings

Indeterminate GlobeNewswire
Next‑Generation 100/1000BASE‑T1 Single Pair Ethernet PHYs Integrate MACsec Security, Time Sensitive Networking and Functional Safety
May 7, 2026

Next‑Generation 100/1000BASE‑T1 Single Pair Ethernet PHYs Integrate MACsec Security, Time Sensitive Networking and Functional Safety

Indeterminate GlobeNewswire
Krystal Biotech to Present at BofA Securities 2026 Health Care Conference
May 7, 2026

Krystal Biotech to Present at BofA Securities 2026 Health Care Conference

Indeterminate GlobeNewswire
vTv Therapeutics to Participate in Upcoming May Investor Conferences
May 7, 2026

vTv Therapeutics to Participate in Upcoming May Investor Conferences

Indeterminate GlobeNewswire
MBX Biosciences Reports First Quarter 2026 Financial Results and Corporate Highlights
May 7, 2026

MBX Biosciences Reports First Quarter 2026 Financial Results and Corporate Highlights

Indeterminate GlobeNewswire
MediWound to Report First Quarter 2026 Financial Results
May 7, 2026

MediWound to Report First Quarter 2026 Financial Results

Indeterminate GlobeNewswire
Diginex Deputy Chairman Discusses Strategic Reset, and Integrated AI‑Driven Platform Strategy in New Investor Interview
May 7, 2026

Diginex Deputy Chairman Discusses Strategic Reset, and Integrated AI‑Driven Platform Strategy in New Investor Interview

Indeterminate GlobeNewswire
ARS Pharmaceuticals Announces Conference Call and Webcast for its First Quarter 2026 Financial Results
May 7, 2026

ARS Pharmaceuticals Announces Conference Call and Webcast for its First Quarter 2026 Financial Results

Indeterminate GlobeNewswire
Praxis Precision Medicines Provides Corporate Update and Reports First Quarter 2026 Financial Results
May 7, 2026

Praxis Precision Medicines Provides Corporate Update and Reports First Quarter 2026 Financial Results

Indeterminate GlobeNewswire
Solid Biosciences Doses First Participant in Phase 3 IMPACT DUCHENNE Clinical Trial Evaluating SGT-003 in Duchenne Muscular Dystrophy
May 7, 2026

Solid Biosciences Doses First Participant in Phase 3 IMPACT DUCHENNE Clinical Trial Evaluating SGT-003 in Duchenne Muscular Dystrophy

Indeterminate GlobeNewswire
Zscaler to Host Third Quarter Fiscal Year 2026 Earnings Conference Call
May 7, 2026

Zscaler to Host Third Quarter Fiscal Year 2026 Earnings Conference Call

Indeterminate GlobeNewswire
ALX Oncology’s Evorpacept in Combination with Zanidatamab Generates Promising, Durable Response in Patients with Advanced HER2-Positive Breast Cancer and High CD47 Expression
May 7, 2026

ALX Oncology’s Evorpacept in Combination with Zanidatamab Generates Promising, Durable Response in Patients with Advanced HER2-Positive Breast Cancer and High CD47 Expression

Indeterminate GlobeNewswire
Filana Therapeutics Reports Q1 2026 Financial Results and Business Update
May 7, 2026

Filana Therapeutics Reports Q1 2026 Financial Results and Business Update

Indeterminate GlobeNewswire
Kaltura Launches Avatar Video Production Studio, Transforming Enterprise Knowledge Into Interactive, Avatar-Led Video Experiences at Scale
May 7, 2026

Kaltura Launches Avatar Video Production Studio, Transforming Enterprise Knowledge Into Interactive, Avatar-Led Video Experiences at Scale

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Nebraska Tech Daily

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.